Glycan mimicry as a basis for novel anti-infective drugs

Biochimie

Volumn 83, Issue 8, 2001, Pages 841-847

  Mulvey, George ^a   Kitov, Pavel I ^a   Marcato, Paola ^a   Bundle, David R ^a   Armstrong, Glen D ^a  

^a UNIVERSITY OF ALBERTA   (Canada)

Author keywords

Adhesion; Anti adhesion; Carbohydrate; Glycoconjugate; Microbial

Indexed keywords

ANTIINFECTIVE AGENT; BACTERIAL TOXIN; CARBOHYDRATE; CARBOHYDRATE DERIVATIVE; GLYCAN; MONOVALENT CATION; SHIGA TOXIN; STARFISH SHIGA TOXIN INHIBITOR; UNCLASSIFIED DRUG;

BACTERIUM ADHERENCE; BINDING AFFINITY; BINDING COMPETITION; CARBOHYDRATE ANALYSIS; CELL SURFACE; DRUG DESIGN; DRUG PROTEIN BINDING; DRUG SCREENING; HOST; HOST CELL; MICROBIOLOGY; NONHUMAN; PATHOGENICITY; REVIEW;

EID: 0034851401     PISSN: 03009084     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0300-9084(01)01291-3     Document Type: Review

References (50)

1. Bacterial adherence: Adhesin receptor-mediated attachment of pathogenic bacteria to mucosal surfaces
2. Safe as mother's milk: Carbohydrates as future antiadhesion drugs for bacterial diseases
3. Toward anti-adhesion therapy for microbial diseases
4. Oligosaccharide anti-infective agents
5. Structural basis of lectin-carbohydrate recognition
6. Lectins
7. Cell-surface carbohydrate recognition by animal and viral lectins
8. Bacterial adherence: Adhesin-receptor interactions mediating attachment of bacteria to mucosal surfaces
9. Polyvalent interactions in biological systems: Implications for design and use of multivalent ligands and inhibitors
10. Colonization factors of human enterotoxigenic Escherichia coli (ETEC)
11. Seven toxic peptides that cross cell membranes
12. Lactose binding to heat-labile enterotoxin revealed by X-ray crystallography
13. Structure of the Shiga-like toxin I B-pentamer complexed with an analogue of its receptor Gb3
14. Role of lactosyl glycan sequences in inhibiting enteropathogenic Escherichia coli attachment
15. Structure-based exploration of the ganglioside GM1 binding sites of Escherichia coli heat-labile enterotoxin and cholera toxin for the discovery of receptor antagonists
16. Structure and energetics of protein-carbohydrate complexes
17. Animal glycosphingolipids as membrane attachment sites for bacteria
18. Two distinct binding sites for globotriaosyl ceramide on verotoxins: Identification by molecular modelling and confirmation using deoxy analogues and a new glycolipid receptor for all verotoxins
19. Aromatic alpha-glycosides of mannose are powerful inhibitors of the adherence of type 1 fimbriated Escherichia coli to yeast and intestinal epithelial cells
20. Shiga-like toxins are neutralized by tailored multivalent carbohydrate ligands
21. High affinity pentavalent ligands of Escherichia coli heat-liable enterotoxin by molecular structure-based design
22. Galactose-binding site in Escherichia coli heat-labile enterotoxin (LT) and cholera toxin (CT)
23. Binding of Vibrio cholera toxin and the heat-labile enterotoxin of Escherichia coli to GM1, derivatives of GM1, and non-lipid oligosaccharide polyvalent ligands
24. Glycolipid binding of purified recombinant Escherichia coli produced verotoxin in vitro
25. The identification of three biologically relevant globotriosyl ceramide receptor binding sites on the Verotoxin 1 B subunit
26. Structural elucidation of the backbone oligosaccharide from the lipopolysaccharide of Moraxella catarrhalis serotype A
27. Structural characterization of the O-polysaccharide produced by Salmonella milwaukee O:43 (group U) which possesses human blood group B activity
28. Structure of the polysaccharide O-antigen of Salmonella riogrande O:40 (group R) related to blood group A activity
29. Simultaneous expression of type 1 and type 2 Lewis blood group antigens by Helicobacter pylori lipopolysaccharides. Molecular mimicry between H. pylori lipopolysaccharides and human gastric epithelial cell surface glycoforms
30. Structure of an alpha-2,6-sialylated lipooligosaccharide from Neisseria meningitidis immunotype L1
31. Lipooligosaccharides (LOS) of mucosal pathogens: Molecular mimicry and host modification of LOS
32. Structural analysis of the lipopolysaccharide oligosaccharide epitopes expressed by a capsule-deficient strain of Haemophilus influenzae Rd.
33. Structure of the variable and conserved lipopolysaccharide oligosaccharide epitopes expressed by Haemophilus influenzae serotype B strain Eagan
34. A new biological agent for treatment of shiga toxigenic Escherichia coli infections and dysentery in humans
35. Oral administration of formaldehyde-killed recombinant bacteria expressing a mimic of the Shiga toxin receptor protects mice from fatal challenge with Shiga-toxigenic Escherichia coli
36. Investigation of Shiga-like toxin binding to chemically synthesized oligosaccharide sequences
37. Clinical trials of Synsorb-Pk in preventing hemolytic-uremic syndrome
38. Common themes in microbial pathogenicity revisited
39. Diarrheagenic Escherichia coli
40. Inhibition of localized adhesion of enteropathogenic Escherichia coli to HEp-2 cells by immunoglobulin and oligosaccharide fractions of human colostrum and breast milk
41. Effect of enteropathogenic Escherichia coli on adherent properties of Chinese hamster ovary cells
42. Secretion of Yop proteins by Yersiniae
43. Secretion of extracellular proteins by enterohemorrhagic Escherichia coli via a putative type III secretion system
44. The invasion associated type III protein secretion system in Salmonella: A review
45. Glycosyltransferases in the synthesis of oligosaccharide analogs
46. Large-scale production of oligosaccharides using engineered bacteria
47. Molscript: A program to produce both detailed and schematic plots of protein structures
48. Raster3D: Photorealistic molecular graphics
49. Down regulation of intimin expression during attaching and effacing enteropathogenic Escherichia coli adhesion